Author : Verevkina N.
Prognostic factors of metastatic luminal (Her2/neu-negative) breast cancerAuthors: Tarasenko T. Syvak L. Verevkina N. Lyalkin S.... T. 10, № 1-2 (37-38)
Recent advances in immunotherapy in the treatment of cancer patients: the use of immunotherapy in non-small cell lung cancerAuthor:Verevkina N. Т. 8, № 4 (32) 2018
The role of ESR1 mutations in development of resistance to hormone therapy in patients with luminal subtypes of breast cancerAuthors: Sivak L.A. Tarasenko T. Lyalkin S. Verevkina N. Т. 8, № 1 (29) 2018
Preservation of fertility in patients with breast cancerAuthors: Sivak L.A. Lyalkin S. Martynyuk O. Dosenko I.... Т. 8, № 1 (29) 2018
Method of improving the quality of life in patients receiving anthracycline-containing chemotherapyAuthors: Askоlskiy А.В. Sivak L.A. Shevchuk L. Mаydаnеvich N.... №2(26) 2017
The influence of allelic polymorphism of the gene CCR5 on the course of locally advanced breast cancerAuthors: Sivak L.A. Verevkina N. Gorovenko N.G. Lyalkin S.... №1(25) 2017
Modern approaches to the treatment of inoperable non-small cell lung cancerAuthors: Klimаnоv М.Yu. Sivak L.A. Tarasenko T. Askоlskiy А.В.... №4(24) 2016
The clinical case of multiple primary cancerAuthors: Sivak L.A. Tarasenko T. Klimаnоv М.Yu. Lyalkin S.... №3(23) 2016
Prognostic and predictive value
of the biological markers in locally advanced breast cancerAuthors: Sivak L.A. Verevkina N. Lyalkin S. Mаydаnеvich N.... №4(20) 2015
Breast cancer prognostic factors. Current state of the problemAuthors: Sivak L.A. Verevkina N. Lyalkin S. №4(16) 2014
